OFM
SPRB

Omega Fund Management’s Spruce Biosciences SPRB Stock Holding History

Omega Fund Management’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-28,814
Closed -$6.33M – 13
2023
Q4 		$6.33M Hold
28,814
– – 5.13% 6
2023
Q3 		$4.88M Hold
28,814
– – 4.49% 6
2023
Q2 		$4.65M Hold
28,814
– – 2.6% 9
2023
Q1 		$4.78M Hold
28,814
– – 3.11% 9
2022
Q4 		$2.33M Hold
28,814
– – 0.79% 13
2022
Q3 		$2.96M Hold
28,814
– – 1.08% 15
2022
Q2 		$3.76M Hold
28,814
– – 1.2% 16
2022
Q1 		$4.34M Hold
28,814
– – 0.89% 16
2021
Q4 		$9.64M Hold
28,814
– – 1.36% 13
2021
Q3 		$13M Hold
28,814
– – 1.46% 13
2021
Q2 		$24.2M Hold
28,814
– – 2.74% 7
2021
Q1 		$35.9M Hold
28,814
– – 3.39% 7
2020
Q4 		$52.5M Buy
+28,814
New +$47.8M 7.88% 4

Other funds holding SPRB

RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
SCM
Superstring Capital Management New York $158M AUM 418.32% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Omega Fund Management's SPRB Position: Q1 2024 in Review

Omega Fund Management sold out of Spruce Biosciences (SPRB) in Q1 2024, closing a stake of 28,814 shares — an estimated $6.33M sold.

Omega Fund Management first reported a position in SPRB in Q4 2020 and held it in 13 quarters. The position peaked at $52.5M in Q4 2020. 49 funds tracked by Wall St. Rank hold SPRB as of Q1 2024.

  • Omega Fund Management reported no remaining Spruce Biosciences position as of Q1 2024 after selling out during the quarter.
  • Omega Fund Management sold 28,814 Spruce Biosciences shares in Q1 2024, an estimated $6.33M.
  • Omega Fund Management first reported a position in Spruce Biosciences in Q4 2020 and held it in 13 quarters.
  • Omega Fund Management's Spruce Biosciences position peaked at $52.5M in Q4 2020.
  • 49 funds tracked by Wall St. Rank held Spruce Biosciences as of Q1 2024.

Based on Omega Fund Management's 13F filing for Q1 2024, filed 14 May 2024.